GlobeNewswire 08/08/2024 Genmab Updates 2024 Financial Guidance
GlobeNewswire 05/08/2024 Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors
GlobeNewswire 05/08/2024 BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 05/08/2024 Genmab Takes Full Control of Acasunlimab Development Program
GlobeNewswire 30/07/2024 BioNTech Announces Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patie...
GlobeNewswire 22/07/2024 BioNTech to Report Second Quarter 2024 Financial Results and Corporate Update on August 5, 2024
GlobeNewswire 28/06/2024 Epcoritamab (TEPKINLY®) Receives Positive CHMP Opinion for the Treatment of Adults with Relapsed/ Re...
GlobeNewswire 27/06/2024 Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the E...
GlobeNewswire 24/06/2024 BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT...
GlobeNewswire 01/06/2024 Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates M...
GlobeNewswire 29/05/2024 BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
GlobeNewswire 21/05/2024 Genmab Completes Acquisition of ProfoundBio
GlobeNewswire 21/05/2024 BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO A...
GlobeNewswire 17/05/2024 BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
GlobeNewswire 14/05/2024 Bolt Biotherapeutics Reports First Quarter 2024 Results, Announces Strategic Pipeline Prioritization...
GlobeNewswire 14/05/2024 Immatics Announces First Quarter 2024 Financial Results and Business Update
GlobeNewswire 06/05/2024 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 02/05/2024 Genmab Announces Financial Results for the First Quarter of 2024
GlobeNewswire 30/04/2024 TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervica...
GlobeNewswire 22/04/2024 BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
GlobeNewswire 07/04/2024 Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persis...
GlobeNewswire 03/04/2024 Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio
GlobeNewswire 20/03/2024 BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 20/03/2024 BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
GlobeNewswire 11/03/2024 BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidat...